Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release

ACS Applied Materials and Interfaces

Volumn 9, Issue 12, 2017, Pages 10567-10576

  Wang, Hangxiang ^a   Wu, Jiaping ^a   Xie, Ke ^a   Fang, Tao ^b   Chen, Chao ^c   Xie, Haiyang ^a   Zhou, Lin ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Jinhua People's Hospital   (China)

^c HUZHOU UNIVERSITY   (China)

Author keywords

antiangiogenesis; cancer nanomedicine; combination therapy; prodrug cocktail; self assembly

Indexed keywords

DISEASES; ESTERS; FATTY ACIDS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; ONCOLOGY; SATURATED FATTY ACIDS; SELF ASSEMBLY;

ALPHA LINOLENIC ACIDS; ANTIANGIOGENESIS; CHEMICAL DERIVATIZATION; COMBINATION THERAPY; CONTROLLABLE DRUG RELEASE; POLYMERIC NANOPARTICLES; PRODRUGS; SYNERGISTIC COMBINATIONS;

POLYMERS;

NANOPARTICLE; POLYMER; PRODRUG;

DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; NEOPLASM;

DRUG DELIVERY SYSTEMS; DRUG LIBERATION; HUMANS; NANOPARTICLES; NEOPLASMS; POLYMERS; PRODRUGS;

EID: 85016569223     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.7b01938     Document Type: Article

References (59)

1. Hanahan, D.; Weinberg, R. A. Hallmarks of Cancer: The Next Generation Cell 2011, 144, 646-674 10.1016/j.cell.2011.02.013
2. Tozer, G. M.; Kanthou, C.; Baguley, B. C. Disrupting Tumour Blood Vessels Nat. Rev. Cancer 2005, 5, 423-435 10.1038/nrc1628
3. Blagosklonny, M. V. Antiangiogenic Therapy and Tumor Progression Cancer Cell 2004, 5, 13-17 10.1016/S1535-6108(03)00336-2
4. Mukherjee, S.; Patra, C. R. Therapeutic Application of Anti-Angiogenic Nanomaterials in Cancers Nanoscale 2016, 8, 12444-12470 10.1039/C5NR07887C
5. Bergers, G.; Hanahan, D. Modes of Resistance to Anti-Angiogenic Therapy Nat. Rev. Cancer 2008, 8, 592-603 10.1038/nrc2442
6. Pathak, R. K.; Marrache, S.; Choi, J. H.; Berding, T. B.; Dhar, S. The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin Angew. Chem., Int. Ed. 2014, 53, 1963-1967 10.1002/anie.201308899
7. Pathak, R. K.; Dhar, S. A Nanoparticle Cocktail: Temporal Release of Predefined Drug Combinations J. Am. Chem. Soc. 2015, 137, 8324-8327 10.1021/jacs.5b03078
8. Lehar, J.; Krueger, A. S.; Avery, W.; Heilbut, A. M.; Johansen, L. M.; Price, E. R.; Rickles, R. J.; Short, G. F., III; Staunton, J. E.; Jin, X.; Lee, M. S.; Zimmermann, G. R.; Borisy, A. A. Synergistic Drug Combinations Tend to Improve Therapeutically Relevant Selectivity Nat. Biotechnol. 2009, 27, 659-666 10.1038/nbt.1549
9. Zhao, Y.; Chen, F.; Pan, Y.; Li, Z.; Xue, X.; Okeke, C. I.; Wang, Y.; Li, C.; Peng, L.; Wang, P. C.; Ma, X.; Liang, X. J. Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance ACS Appl. Mater. Interfaces 2015, 7, 19295-19305 10.1021/acsami.5b05347
10. Mallick, A.; More, P.; Ghosh, S.; Chippalkatti, R.; Chopade, B. A.; Lahiri, M.; Basu, S. Dual Drug Conjugated Nanoparticle for Simultaneous Targeting of Mitochondria and Nucleus in Cancer Cells ACS Appl. Mater. Interfaces 2015, 7, 7584-7598 10.1021/am5090226
11. Maksimenko, A.; Alami, M.; Zouhiri, F.; Brion, J. D.; Pruvost, A.; Mougin, J.; Hamze, A.; Boissenot, T.; Provot, O.; Desmaele, D.; Couvreur, P. Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer: An Ongoing Search for Improved Efficacy ACS Nano 2014, 8, 2018-2032 10.1021/nn500517a
12. Sengupta, S.; Eavarone, D.; Capila, I.; Zhao, G.; Watson, N.; Kiziltepe, T.; Sasisekharan, R. Temporal Targeting of Tumour Cells and Neovasculature with a Nanoscale Delivery System Nature 2005, 436, 568-572 10.1038/nature03794
13. Maeda, H.; Nakamura, H.; Fang, J. The Epr Effect for Macromolecular Drug Delivery to Solid Tumors: Improvement of Tumor Uptake, Lowering of Systemic Toxicity, and Distinct Tumor Imaging in Vivo Adv. Drug Delivery Rev. 2013, 65, 71-79 10.1016/j.addr.2012.10.002
14. Seeta Rama Raju, G.; Benton, L.; Pavitra, E.; Yu, J. S. Multifunctional Nanoparticles: Recent Progress in Cancer Therapeutics Chem. Commun. 2015, 51, 13248-13259 10.1039/C5CC04643B
15. Lee, S. W.; Yun, M. H.; Jeong, S. W.; In, C. H.; Kim, J. Y.; Seo, M. H.; Pai, C. M.; Kim, S. O. Development of Docetaxel-Loaded Intravenous Formulation, Nanoxel-Pm Using Polymer-Based Delivery System J. Controlled Release 2011, 155, 262-271 10.1016/j.jconrel.2011.06.012
16. Fornaguera, C.; Caldero, G.; Mitjans, M.; Vinardell, M. P.; Solans, C.; Vauthier, C. Interactions of Plga Nanoparticles with Blood Components: Protein Adsorption, Coagulation, Activation of the Complement System and Hemolysis Studies Nanoscale 2015, 7, 6045-6058 10.1039/C5NR00733J
17. Zhang, H.; Hu, H.; Zhang, H.; Dai, W.; Wang, X.; Wang, X.; Zhang, Q. Effects of Pegylated Paclitaxel Nanocrystals on Breast Cancer and Its Lung Metastasis Nanoscale 2015, 7, 10790-10800 10.1039/C4NR07450E
18. Yang, X. R.; Wu, S. C.; Li, Y.; Huang, Y.; Lin, J. Y.; Chang, D.; Ye, S. F.; Xie, L. Y.; Jiang, Y.; Hou, Z. Q. Integration of an Anti-Tumor Drug into Nanocrystalline Assemblies for Sustained Drug Release Chem. Sci. 2015, 6, 1650-1654 10.1039/C4SC03392B
19. Fornaguera, C.; Feiner-Gracia, N.; Caldero, G.; Garcia-Celma, M. J.; Solans, C. Galantamine-Loaded Plga Nanoparticles, from Nano-Emulsion Templating, as Novel Advanced Drug Delivery Systems to Treat Neurodegenerative Diseases Nanoscale 2015, 7, 12076-12084 10.1039/C5NR03474D
20. Jiang, C.; Wang, H.; Zhang, X.; Sun, Z.; Wang, F.; Cheng, J.; Xie, H.; Yu, B.; Zhou, L. Deoxycholic Acid-Modified Chitooligosaccharide/Mpeg-Pdlla Mixed Micelles Loaded with Paclitaxel for Enhanced Antitumor Efficacy Int. J. Pharm. 2014, 475, 60-68 10.1016/j.ijpharm.2014.08.037
21. Wang, H.; Chen, W.; Xie, H.; Wei, X.; Yin, S.; Zhou, L.; Xu, X.; Zheng, S. Biocompatible, Chimeric Peptide-Condensed Supramolecular Nanoparticles for Tumor Cell-Specific Sirna Delivery and Gene Silencing Chem. Commun. 2014, 50, 7806-7809 10.1039/c4cc01061b
22. Song, W. T.; Tang, Z. H.; Zhang, D. W.; Li, M. Q.; Gu, J. K.; Chen, X. S. A Cooperative Polymeric Platform for Tumor-Targeted Drug Delivery Chem. Sci. 2016, 7, 728-736 10.1039/C5SC01698C
23. Kamaly, N.; Xiao, Z.; Valencia, P. M.; Radovic-Moreno, A. F.; Farokhzad, O. C. Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation Chem. Soc. Rev. 2012, 41, 2971-3010 10.1039/c2cs15344k
24. Yu, Z.; Schmaltz, R. M.; Bozeman, T. C.; Paul, R.; Rishel, M. J.; Tsosie, K. S.; Hecht, S. M. Selective Tumor Cell Targeting by the Disaccharide Moiety of Bleomycin J. Am. Chem. Soc. 2013, 135, 2883-2886 10.1021/ja311090e
25. Ma, L.; Kohli, M.; Smith, A. Nanoparticles for Combination Drug Therapy ACS Nano 2013, 7, 9518-9525 10.1021/nn405674m
26. Lee, S. M.; O'Halloran, T. V.; Nguyen, S. T. Polymer-Caged Nanobins for Synergistic Cisplatin-Doxorubicin Combination Chemotherapy J. Am. Chem. Soc. 2010, 132, 17130-17138 10.1021/ja107333g
27. Ramasamy, T.; Ruttala, H. B.; Choi, J. Y.; Tran, T. H.; Kim, J. H.; Ku, S. K.; Choi, H. G.; Yong, C. S.; Kim, J. O. Engineering of a Lipid-Polymer Nanoarchitectural Platform for Highly Effective Combination Therapy of Doxorubicin and Irinotecan Chem. Commun. 2015, 51, 5758-5761 10.1039/C5CC00482A
28. Zheng, Y. R.; Suntharalingam, K.; Johnstone, T. C.; Lippard, S. J. Encapsulation of Pt(Iv) Prodrugs within a Pt(Ii) Cage for Drug Delivery Chem. Sci. 2015, 6, 1189-1193 10.1039/C4SC01892C
29. Xiao, W.; Zeng, X.; Lin, H.; Han, K.; Jia, H. Z.; Zhang, X. Z. Dual Stimuli-Responsive Multi-Drug Delivery System for the Individually Controlled Release of Anti-Cancer Drugs Chem. Commun. 2015, 51, 1475-1478 10.1039/C4CC08831J
30. Zhou, S. W.; Sha, H. Z.; Liu, B. R.; Du, X. Z. Integration of Simultaneous and Cascade Release of Two Drugs into Smart Single Nanovehicles Based on DNA-Gated Mesoporous Silica Nanoparticles Chem. Sci. 2014, 5, 4424-4433 10.1039/C4SC01195C
31. Fan, L.; Jin, B.; Zhang, S.; Song, C.; Li, Q. Stimuli-Free Programmable Drug Release for Combination Chemo-Therapy Nanoscale 2016, 8, 12553-12559 10.1039/C5NR06305A
32. Wang, H.; Xie, H.; Wu, J.; Wei, X.; Zhou, L.; Xu, X.; Zheng, S. Structure-Based Rational Design of Prodrugs to Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy Angew. Chem., Int. Ed. 2014, 53, 11532-11537 10.1002/anie.201406685
33. Wang, H.; Xie, H.; Wang, J.; Wu, J.; Ma, X.; Li, L.; Wei, X.; Ling, Q.; Song, P.; Zhou, L.; Xu, X.; Zheng, S. Self-Assembling Prodrugs by Precise Programming of Molecular Structures That Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy Adv. Funct. Mater. 2015, 25, 4956-4965 10.1002/adfm.201501953
34. Fang, T.; Dong, Y.; Zhang, X.; Xie, K.; Lin, L.; Wang, H. Integrating a Novel SN38 Prodrug into the Pegylated Liposomal System as a Robust Platform for Efficient Cancer Therapy in Solid Tumors Int. J. Pharm. 2016, 512, 39-48 10.1016/j.ijpharm.2016.08.036
35. Davies, J. T. A Quantitative Kinetic Theory of Emulsion Type, I. Physical Chemistry of the Emulsifying Agent Proc. 2. Int. Congr. Surf. Act. London 1957, 1, 426-438
36. Degen, P.; Leick, S.; Rehage, H.; Polkowska, J.; Klärner, F. G. Gemini-Like Molecular Clips and Tweezers: The Influence of Structure and Guest Binding on Interfacial Tension Langmuir 2009, 25, 6094-6099 10.1021/la900072w
37. Liang, C. C.; Park, A. Y.; Guan, J. L. In Vitro Scratch Assay: A Convenient and Inexpensive Method for Analysis of Cell Migration in Vitro Nat. Protoc. 2007, 2, 329-333 10.1038/nprot.2007.30
38. Huang, Y.; Yang, X.; Xu, T.; Kong, Q.; Zhang, Y.; Shen, Y.; Wei, Y.; Wang, G.; Chang, K. J. Overcoming Resistance to Trail-Induced Apoptosis in Solid Tumor Cells by Simultaneously Targeting Death Receptors, C-Flip and Iaps Int. J. Oncol. 2016, 49, 153-163 10.3892/ijo.2016.3525
39. Kwong, W.-L.; Lam, K.-Y.; Lok, C.-N.; Lai, Y.-T.; Lee, P.-Y.; Che, C.-M. A Macrocyclic Ruthenium(Iii) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth in Vivo Angew. Chem., Int. Ed. 2016, 55, 13524-13528 10.1002/anie.201608094
40. Lai, P.-X.; Chen, C.-W.; Wei, S.-C.; Lin, T.-Y.; Jian, H.-J.; Lai, I. P.-J.; Mao, J.-Y.; Hsu, P.-H.; Lin, H.-J.; Tzou, W.-S.; Chen, S.-Y.; Harroun, S. G.; Lai, J.-Y.; Huang, C.-C. Ultrastrong Trapping of Vegf by Graphene Oxide: Anti-Angiogenesis Application Biomaterials 2016, 109, 12-22 10.1016/j.biomaterials.2016.09.005
41. Vincent, L.; Kermani, P.; Young, L. M.; Cheng, J.; Zhang, F.; Shido, K.; Lam, G.; Bompais-Vincent, H.; Zhu, Z. P.; Hicklin, D. J.; Bohlen, P.; Chaplin, D. J.; May, C.; Rafii, S. Combretastatin A4 Phosphate Induces Rapid Regression of Tumor Neovessels and Growth through Interference with Vascular Endothelial-Cadherin Signaling J. Clin. Invest. 2005, 115, 2992-3006 10.1172/JCI24586
42. Tron, G. C.; Pirali, T.; Sorba, G.; Pagliai, F.; Busacca, S.; Genazzani, A. A. Medicinal Chemistry of Combretastatin A4: Present and Future Directions J. Med. Chem. 2006, 49, 3033-3044 10.1021/jm0512903
43. Jeong, B.; Bae, Y. H.; Lee, D. S.; Kim, S. W. Biodegradable Block Copolymers as Injectable Drug-Delivery Systems Nature 1997, 388, 860-862 10.1038/42218
44. Wang, J.; Wang, H.; Li, J.; Liu, Z.; Xie, H.; Wei, X.; Lu, D.; Zhuang, R.; Xu, X.; Zheng, S. iRGD-Decorated Polymeric Nanoparticles for the Efficient Delivery of Vandetanib to Hepatocellular Carcinoma: Preparation and in Vitro and in Vivo Evaluation ACS Appl. Mater. Interfaces 2016, 8, 19228-19237 10.1021/acsami.6b03166
45. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in Vivo Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 6315-6320 10.1073/pnas.0601755103
46. Beck-Broichsitter, M.; Nicolas, J.; Couvreur, P. Solvent Selection Causes Remarkable Shifts of the ″Ouzo Region″ for Poly(Lactide-Co-Glycolide) Nanoparticles Prepared by Nanoprecipitation Nanoscale 2015, 7, 9215-9221 10.1039/C5NR01695A
47. Lu, H. D.; Wilson, B. K.; Heinmiller, A.; Faenza, B.; Hejazi, S.; Prud'homme, R. K. Narrow Absorption Nir Wavelength Organic Nanoparticles Enable Multiplexed Photoacoustic Imaging ACS Appl. Mater. Interfaces 2016, 8, 14379-14388 10.1021/acsami.6b03059
48. Rabanel, J. M.; Faivre, J.; Tehrani, S. F.; Lalloz, A.; Hildgen, P.; Banquy, X. Effect of the Polymer Architecture on the Structural and Biophysical Properties of Peg-Pla Nanoparticles ACS Appl. Mater. Interfaces 2015, 7, 10374-10385 10.1021/acsami.5b01423
49. Zhang, M. S. S.; Waldron, K. C.; Zhu, X. X.; Strandman, S. Supramolecular Hydrogelation with Bile Acid Derivatives Structures, Properties and Applications J. Mater. Chem. B 2016, 4, 7506 10.1039/C6TB02270G
50. Rautio, J.; Kumpulainen, H.; Heimbach, T.; Oliyai, R.; Oh, D.; Jarvinen, T.; Savolainen, J. Prodrugs: Design and Clinical Applications Nat. Rev. Drug Discovery 2008, 7, 255-270 10.1038/nrd2468
51. Matsumoto, Y.; Nichols, J. W.; Toh, K.; Nomoto, T.; Cabral, H.; Miura, Y.; Christie, R. J.; Yamada, N.; Ogura, T.; Kano, M. R.; Matsumura, Y.; Nishiyama, N.; Yamasoba, T.; Bae, Y. H.; Kataoka, K. Vascular Bursts Enhance Permeability of Tumour Blood Vessels and Improve Nanoparticle Delivery Nat. Nanotechnol. 2016, 11, 533-538 10.1038/nnano.2015.342
52. Kerbel, R.; Folkman, J. Clinical Translation of Angiogenesis Inhibitors Nat. Rev. Cancer 2002, 2, 727-739 10.1038/nrc905
53. Iyer, S.; Chaplin, D. J.; Rosenthal, D. S.; Boulares, A. H.; Li, L. Y.; Smulson, M. E. Induction of Apoptosis in Proliferating Human Endothelial Cells by the Tumor-Specific Antiangiogenesis Agent Combretastatin A-4 Cancer Res. 1998, 58, 4510-4514
54. Xie, H.; Xu, X.; Chen, J.; Li, L.; Wang, J.; Fang, T.; Zhou, L.; Wang, H.; Zheng, S. Rational Design of Multifunctional Small-Molecule Prodrugs for Simultaneous Suppression of Cancer Cell Growth and Metastasis in Vitro and in Vivo Chem. Commun. 2016, 52, 5601-5604 10.1039/C5CC10367C
55. Liao, W.; Lai, T.; Chen, L.; Fu, J.; Sreenivasan, S. T.; Yu, Z.; Ren, J. Synthesis and Characterization of a Walnut Peptides-Zinc Complex and Its Antiproliferative Activity against Human Breast Carcinoma Cells through the Induction of Apoptosis J. Agric. Food Chem. 2016, 64, 1509-1519 10.1021/acs.jafc.5b04924
56. Petit, I.; Karajannis, M. A.; Vincent, L.; Young, L.; Butler, J.; Hooper, A. T.; Shido, K.; Steller, H.; Chaplin, D. J.; Feldman, E.; Rafii, S. The Microtubule-Targeting Agent CA4P Regresses Leukemic Xenografts by Disrupting Interaction with Vascular Cells and Mitochondrial-Dependent Cell Death Blood 2008, 111, 1951-1961 10.1182/blood-2007-05-089219
57. Vargas, A.; Zeisserlabouebe, M.; Lange, N.; Gurny, R.; Delie, F. The Chick Embryo and Its Chorioallantoic Membrane (CAM) for the in Vivo Evaluation of Drug Delivery Systems Adv. Drug Delivery Rev. 2007, 59, 1162-1176 10.1016/j.addr.2007.04.019
58. Ribatti, D.; Nico, B.; Vacca, A.; Presta, M. The Gelatin Sponge-Chorioallantoic Membrane Assay Nat. Protoc. 2006, 1, 85-91 10.1038/nprot.2006.13
59. Albelda, S. M.; Muller, W. A.; Buck, C. A.; Newman, P. J. Molecular and Cellular Properties of Pecam-1 (Endocam/CD31): A Novel Vascular Cell-Cell Adhesion Molecule J. Cell Biol. 1991, 114, 1059-1068 10.1083/jcb.114.5.1059